Abstract:AXIN1 and AXIN2 are highly related proteins that inhibit the proto‐oncogenic Wnt/β‐catenin pathway. Both proteins are degraded through a tankyrase (TNKS)‐dependent mechanism. Here, we show that AXIN2 promotes TNKS‐mediated degradation of AXIN1. Mechanistically, AXIN2 recruits TNKS into AXIN1 condensates because it interacts with both components. Concordantly, loss of AXIN2 disrupted regulation of AXIN1 expression by TNKS in SW480 colorectal cancer cells, which may have therapeutic implications for colorectal cancer through TNKS inhibitors. AXIN1 and AXIN2 are homologous proteins that inhibit the Wnt/β‐catenin signaling pathway, which is frequently hyperactive in colorectal cancer. Stabilization of AXIN1 and AXIN2 by inhibiting their degradation through tankyrase (TNKS) allows the attenuation of Wnt signaling in cancer, attracting interest for potential targeted therapy. Here, we found that knockout or knockdown of AXIN2 in colorectal cancer cells increased the protein stability of AXIN1. The increase in AXIN1 overcompensated for the loss of AXIN2 with respect to protein levels; however, functionally it did not because loss of AXIN2 activated the pathway. Moreover, AXIN2 was highly essential in the context of TNKS inhibition because TNKS‐targeting small‐molecule inhibitors completely failed to inhibit Wnt signaling and to stabilize AXIN1 in AXIN2 knockout cells. The increased AXIN1 protein stability and the impaired stabilization by TNKS inhibitors indicated disrupted TNKS‐AXIN1 regulation in AXIN2 knockout cells. Concordantly, mechanistic studies revealed that co‐expression of AXIN2 recruited TNKS to AXIN1 and stimulated TNKS‐mediated degradation of transiently expressed AXIN1 wild‐type and AXIN1 mutants with impaired TNKS binding. Taken together, our data suggest that AXIN2 promotes degradation of AXIN1 through TNKS in colorectal cancer cells by directly linking the two proteins, and these findings may be relevant for TNKS inhibition‐based colorectal cancer therapies.

Axin Is Localized within Mitochondria and Regulates Energy Metabolism through Alterations of Oxidative Phosphorylation and Glycolysis

Axin-Induced Apoptosis Depends on the Extent of Its JNK Activation and Its Ability to Down-Regulate Β-Catenin Levels

Roles of Axin in the Wnt Signaling Pathway

The scaffold protein AXIN1: gene ontology, signal network, and physiological function

AXIN2 is a non‐redundant regulator of AXIN1 stability and β‐catenin in colorectal cancer cells

Hypoxia exposure induces lactylation of Axin1 protein to promote glycolysis of esophageal carcinoma cells

Dynamin Regulates Autophagy by Modulating Lysosomal Function

Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.

Axin and GSK3- Control Smad3 Protein Stability and Modulate TGF- Signaling.

Axin is a scaffold protein in TGF-beta signaling that promotes degradation of Smad7 by Arkadia.

Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation

Analysis of tumor-associated AXIN1 missense mutations identifies variants that activate β-catenin signaling

Overexpression of Axin Downregulates TCF-4 and Inhibits the Development of Lung Cancer.

X-linked Inhibitor of Apoptosis Protein (XIAP) Mediates Cancer Cell Motility Via Rho GDP Dissociation Inhibitor (Rhogdi)-Dependent Regulation of the Cytoskeleton

Arp2/3-Branched Actin Regulates Microtubule Acetylation Level And Affects Mitochondria Distribution.

The Acyl‐coa‐binding Protein Acb1 Regulates Mitochondria, Lipid Droplets, and Cell Proliferation

Axin 2 controls bone remodeling through the β-catenin – BMP signaling pathway in adult mice

Structural Basis of the Interaction between Human Axin2 and SIAH1 in the Wnt/β-Catenin Signaling Pathway

Arp2/3-branched actin regulates microtubule acetylation levels and affects mitochondrial distribution

NIPSNAP3A regulates cellular homeostasis by modulating mitochondrial dynamics

AXIN2 promotes degradation of AXIN1 through tankyrase in colorectal cancer cells